Anti-liver damage, promote the body's normal immune function, and restore the liver's normal detoxification function

Enhance the body's ability to resist viruses, and inhibit the increase of serum alanine aminotransferase (SGPT), aspartate aminotransferase (SGOT) and lactate dehydrogenase (LDH)

Start the liver's self-healing system, block the autoimmune response, and significantly increase the plasma Hb content

Promote the body's normal immune function, enhance the body's ability to resist viruses

Fluconazole is a new triazole antifungal drug with a broad-spectrum antifungal effect. It can selectively inhibit the sterol synthesis of fungi. It is effective against Candida infection, Cryptococcus neoformans infection, Malassezia sacchariflora, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, Peyer's Chromatid, and Cladosporium carinii. It has a highly selective inhibitory effect on fungal cytochrome p-450-dependent enzymes.

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

It can inhibit the synthesis of DNA and RNA and glucose metabolism of cell lines such as S-180 sarcoma, Ehrlich ascites carcinoma and human tongue squamous cell carcinoma Tca8113 in vitro; it can inhibit the growth of Ehrlich ascites carcinoma, S-180 sarcoma and HePA liver cancer ascites tumor in vivo (tumor inhibition rate 63%), increase peripheral leukocytes, enhance the phagocytic function of the reticuloendothelial system, activate macrophages and lymphocytes, induce thymus lymphocytes to produce active substances, improve and enhance the body's immune function and stress capacity. After being injected into the human body, this product has the effect of activating phagocytes, NK cells, and T.B cell subsets; it has the effect of inducing interferon and interleukin. It can cause chromosomes of tumor cells, viruses, etc. to break and cause apoptosis, and can induce a variety of effector cells and cytokines to produce a "cytokine cocktail" effect, killing viruses and pathogens broadly and inducing tumor cell apoptosis broadly.